title: Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients.
abstract: The objective of this study was to develop and validate a time-dependent logistic regression model for prediction of locoregional recurrence (LRR) of breast cancer and a web-based nomogram for clinical decision support. Women first diagnosed with early breast cancer between 2003 and 2006 in all Dutch hospitals were selected from the Netherlands Cancer Registry (n = 37,230). In the first 5 years following primary breast cancer treatment, 950 (2.6 %) patients developed a LRR as first event. Risk factors were determined using logistic regression and the risks were calculated per year, conditional on not being diagnosed with recurrence in the previous year. Discrimination and calibration were assessed. Bootstrapping was used for internal validation. Data on primary tumours diagnosed between 2007 and 2008 in 43 Dutch hospitals were used for external validation of the performance of the nomogram (n = 12,308). The final model included the variables grade, size, multifocality, and nodal involvement of the primary tumour, and whether patients were treated with radio-, chemo- or hormone therapy. The index cohort showed an area under the ROC curve of 0.84, 0.77, 0.70, 0.73 and 0.62, respectively, per subsequent year after primary treatment. Model predictions were well calibrated. Estimates in the validation cohort did not differ significantly from the index cohort. The results were incorporated in a web-based nomogram ( http://www.utwente.nl/mira/influence ). This validated nomogram can be used as an instrument to identify patients with a low or high risk of LRR who might benefit from a less or more intensive follow-up after breast cancer and to aid clinical decision making for personalised follow-up.
authors.affiliation: Department of Health Technology and Services Research (HTSR), MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE, Enschede, The Netherlands, a.witteveen@utwente.nl.
authors.forename: Annemieke
authors.initials: A
authors.lastname: Witteveen
authors.forename: Ingrid M H
authors.initials: IM
authors.lastname: Vliegen
authors.forename: Gabe S
authors.initials: GS
authors.lastname: Sonke
authors.forename: Joost M
authors.initials: JM
authors.lastname: Klaase
authors.forename: Maarten J
authors.initials: MJ
authors.lastname: IJzerman
authors.forename: Sabine
authors.initials: S
authors.lastname: Siesling
mesh_terms: D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016015:Logistic Models; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D009426:Netherlands; D049451:Nomograms; D057285:Precision Medicine / Q000379:methods*; D011379:Prognosis; D015203:Reproducibility of Results